The relationship between socioeconomic position and cardiovascular mortality is one of the most robust findings in all of epidemiology. It has been replicated in every country where the data exists to examine it, across multiple measures of socioeconomic status, across different health systems, and across different time periods. And in Europe, despite decades of medical progress and the introduction or strengthening of universal healthcare systems, the gradient is not narrowing. In many countries, it is widening.
How the Gradient Is Measured
Socioeconomic status is not a single variable. Epidemiologists use three principal measures — income, education, and occupational class — which are related but distinct. Income affects cardiovascular health most directly through its material consequences: the ability to afford adequate housing, nutritious food, leisure time, and stress-reducing activities. Education affects cardiovascular health through health literacy and through its effects on employment and income. Occupational class captures both material conditions and the psychosocial dimensions of work: job control, workplace stress, physical hazards, and the security of employment.
All three measures independently predict cardiovascular outcomes, and their effects accumulate. Someone who is low on all three dimensions faces substantially higher cardiovascular risk than someone who is low on one.
Spain: A Case Study
Spain presents a particularly instructive case because it combines universal healthcare coverage with some of the most marked cardiovascular inequalities in western Europe. The Sistema Nacional de Salud provides comprehensive free-at-point-of-care services to all legal residents, including cardiovascular medications, hospital treatment, and surgical interventions. Yet a 2021 analysis of cardiovascular mortality data from Spanish regions found that the socioeconomic gradient in cardiovascular death rates had widened significantly between 2000 and 2018.
The Madrid data are stark. A male resident of Salamanca, one of the city’s wealthiest districts, has a life expectancy approximately seven years longer than a male resident of Vallecas. The primary driver of this gap is cardiovascular disease. This is not a gap that can be explained by differential access to cardiac services: both residents are covered by the same healthcare system. The gap reflects upstream conditions: housing, employment security, environmental stressors, and the neighbourhood-level risk factors that accumulate to generate cardiovascular risk before it becomes a clinical emergency.
The UK: Universal Coverage, Persistent Inequality
The United Kingdom presents a similar picture. The National Health Service, free at the point of use since 1948, has not eliminated cardiovascular inequality. The 2020 Marmot Review found that the gap in life expectancy between the most and least deprived areas of England had widened since 2010. In Scotland, where cardiovascular mortality data are particularly detailed, the absolute gap in heart disease death rates between the most and least deprived quintiles of the population remains larger than it was in the 1990s.
This persistence of inequality despite universal healthcare is sometimes invoked to argue against further investment in health systems. The correct conclusion is the opposite: it demonstrates that healthcare provision, while necessary, is insufficient to address inequalities whose roots lie in the social and economic conditions that precede clinical presentation.
What Interventions Have Evidence Behind Them
The interventions with the strongest evidence for reducing socioeconomic cardiovascular inequality operate at multiple levels simultaneously. Cash transfer programmes that raise income among the poorest families have measurable effects on cardiovascular risk factors. Housing improvement programmes — insulation, heating, damp removal — improve cardiovascular outcomes among residents. Urban regeneration that addresses neighbourhood environmental quality reduces the environmental contributors to cardiovascular risk.
None of these is a cardiovascular intervention in the traditional sense. None involves a statin prescription or a blood pressure monitor. They address the conditions that cause the conditions — and the evidence from European natural experiments consistently shows that upstream interventions can reduce the gradient that downstream medicine has largely failed to close. The cardiovascular inequality problem is not medically intractable. Community-based approaches like the CMSc Villaverde model demonstrate that neighbourhood-level investment can reduce the burden even within these structural constraints. It is politically intractable. That is a different kind of problem.
